Search

everythinglearnresearchcommunity

for

Search:↓

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Finasteride effectively treats BPH, but needs more trials to understand potential.

TRH stimulates human hair growth and extends the hair growth phase.

Thymosin β4 and VEGF are important for blood vessel formation in many organs.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Castration significantly reduces prostate size and BPH symptoms.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Collagen makes skin stiff, and preservation methods greatly increase tissue stiffness.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Sox21 is crucial for tooth development and enamel formation by preventing cells from changing into a different type.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Testosterone increases fluid secretion and aquaporin expression in the vas deferens, which is important for male fertility.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.